Stock AHEALTH APEX HEALTHCARE
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Apex Healthcare

Equities

AHEALTH

MYL7090OO003

End-of-day quote BURSA MALAYSIA
Other stock markets
 23:00:00 07/05/2024 BST 		5-day change 1st Jan Change
3.39 MYR +2.73% Intraday chart for Apex Healthcare +2.73% +36.14%
04-15 Apex Healthcare Berhad Proposes the Special Dividend for the Financial Year Ended 31 December 2023 CI
02-22 Apex Healthcare Boosts Dividend Despite Profit Decline in Q4 MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • The company is in a robust financial situation considering its net cash and margin position.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • The firm trades with high earnings multiples: 25.6 times its 2024 earnings per share.
  • The company is highly valued given the cash flows generated by its activity.
  • The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

Ratings chart - Surperformance

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
APEX HEALTHCARE Stock Apex Healthcare
+36.14% 514M -
MCKESSON CORPORATION Stock McKesson Corporation
+17.42% 70.67B
C+
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
-3.33% 23.73B
C+
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+7.71% 8.26B
B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-19.61% 8.07B
B-
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+1.47% 8.28B
C
H. LUNDBECK A/S Stock H. Lundbeck A/S
+5.56% 4.8B
B-
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+15.41% 4.26B
B+
EBOS GROUP LIMITED Stock EBOS Group Limited
-0.87% 4.08B
B-
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+23.20% 3.68B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. AHEALTH Stock
  4. Ratings Apex Healthcare